D2 Antagonist Augmentation in Patients with a Partial Response to Atypical Antipsychotics [4]

Canadian Journal of Psychiatry

Volumn 49, Issue 4, 2004, Pages 281-282

  Mazeh, Doron ^a   Melamed, Yuval ^a   Weizman, Abraham ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOTIAPINE; CLOZAPINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; HALOPERIDOL; OLANZAPINE; PERPHENAZINE; ZUCLOPENTHIXOL; DOPAMINE 2 RECEPTOR; NEUROLEPTIC AGENT;

ADULT; CASE REPORT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESPONSE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; LETTER; MALE; MONOTHERAPY; SCHIZOPHRENIA; SIDE EFFECT; TARDIVE DYSKINESIA; DOSE RESPONSE; DRUG ANTAGONISM; MIDDLE AGED;

ADULT; ANTIPSYCHOTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA;

EID: 2342556443     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370404900413     Document Type: Letter

References (9)

1. Lalonde P. Evaluating antipsychotic medications: predictors of clinical effectiveness. Report of an expert review panel on efficacy and effectiveness. Can J Psychiatry 2003;48(Suppl 1):3S-12S.
2. Tandon R, Jibson MD. Efficacy of newer generation antipsychotics in the treatment of schizophrenia. Psychoneuroendocrinology 2003;28(Suppl 1):9-26.
3. Taylor DM, Young C, Paton C. Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review. J Clin Psychiatry 2003;64(1):30-4.
4. Beasley CM, Tollefson G, Tran P, Satterlee W, Sanger T, Hamilton S. Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology 1996;14:111-23.
5. Kapur S, Remington G. Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient. Biol Psychiatry 2001;50:873-83.
6. Jaffe AB, Levine J. Antipsychotic medication coprescribing in a large state hospital system. Pharmacoepidemiol Drug Saf 2003;12:41-8.
7. Miller AL, Chiles JA, Chiles JK, Crismon ML, Rush J, Shon SP. The Texas Medication Algorithm Project (TMAP) schizophrenia algorithms. J Clin Psychiatry 1999;60:10:649-57.
8. Gupta S, Sonnenberg SJ, Frank B. Olanzapine augmentation of clozapine. Ann Clin Psychiatry 1998;10:113-5.
9. McCarthy RH, Terkelsen KG. Risperidone augmentation of clozapine. Pharmacopsychiatry 1995;28(2):61-3.